Stanley Druckenmiller Teva Pharmaceutical Industries LTD Transaction History
Duquesne Family Office LLC
- $3.72 Billion
- Q4 2024
A detailed history of Stanley Druckenmiller (Duquesne Family Office LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Duquesne Family Office LLC holds 8,997,400 shares of TEVA stock, worth $141 Million. This represents 5.33% of its overall portfolio holdings.
Number of Shares
8,997,400
Previous 1,427,950
530.09%
Holding current value
$141 Million
Previous $25.7 Million
670.65%
% of portfolio
5.33%
Previous 0.87%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
677Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$674 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$611 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$575 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$445 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$427 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $17.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...